Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AmpC Beta-lactamase”

6 trials

Showing 6 of 6 results

Post-approval studies (Phase 4)Study completedNCT02437045
What this trial is testing

Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response

Who this might be right for
Bloodstream Infections
The University of Queensland 100
Not applicableStudy completedNCT00414193
What this trial is testing

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

Who this might be right for
BacteremiaAmpC Beta-lactamase
University of Pittsburgh 1,000
Post-approval studies (Phase 4)WithdrawnNCT01543347
What this trial is testing

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Who this might be right for
Urinary Tract Infection
Belpharma s.a.
Post-approval studies (Phase 4)WithdrawnNCT05355350
What this trial is testing

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus
Not applicableStudy completedNCT04577989
What this trial is testing

Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital

Who this might be right for
Infection With AmpC Beta-lactamase Producing Enterobacterales
University Hospital, Basel, Switzerland 270
Large-scale testing (Phase 3)WithdrawnNCT04238390
What this trial is testing

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection

Who this might be right for
Bacteremia Caused by Gram-Negative Bacteria
The University of Queensland

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation